Insurance and the High Prices of Pharmaceuticals


The researchers present a model in which prospective patients are liquidity constrained, and thus health insurance allows patients access to treatments and services that they otherwise would have been unable to afford. Consistent with large expansions of insurance in the United States (e.g., the Affordable Care Act), they assume that policies expand the set… (More)


11 Figures and Tables

Cite this paper

@inproceedings{Besanko2016InsuranceAT, title={Insurance and the High Prices of Pharmaceuticals}, author={David Besanko and David Dranove and W J Mcnerney}, year={2016} }